BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38290090)

  • 1. Association of Plasma YKL-40 With MRI, CSF, and Cognitive Markers of Brain Health and Dementia.
    Pase MP; Himali JJ; Puerta R; Beiser AS; Gonzales MM; Satizabal CL; Yang Q; Aparicio HJ; Kojis DJ; Decarli CS; Lopez OL; Longstreth W; Gudnason V; Mosley TH; Bis JC; Fohner A; Psaty BM; Boada M; García-González P; Valero S; Marquié M; Tracy R; Launer LJ; Ruiz A; Fornage M; Seshadri S
    Neurology; 2024 Feb; 102(4):e208075. PubMed ID: 38290090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.
    Howell JC; Watts KD; Parker MW; Wu J; Kollhoff A; Wingo TS; Dorbin CD; Qiu D; Hu WT
    Alzheimers Res Ther; 2017 Nov; 9(1):88. PubMed ID: 29096697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
    Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
    JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
    Kester MI; Teunissen CE; Sutphen C; Herries EM; Ladenson JH; Xiong C; Scheltens P; van der Flier WM; Morris JC; Holtzman DM; Fagan AM
    Alzheimers Res Ther; 2015 Sep; 7(1):59. PubMed ID: 26383836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes.
    Pase MP; Beiser AS; Himali JJ; Satizabal CL; Aparicio HJ; DeCarli C; Chêne G; Dufouil C; Seshadri S
    JAMA Neurol; 2019 May; 76(5):598-606. PubMed ID: 30830207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD.
    Gispert JD; Monté GC; Falcon C; Tucholka A; Rojas S; Sánchez-Valle R; Antonell A; Lladó A; Rami L; Molinuevo JL
    Neurobiol Aging; 2016 Feb; 38():47-55. PubMed ID: 26827642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease.
    Janelidze S; Mattsson N; Stomrud E; Lindberg O; Palmqvist S; Zetterberg H; Blennow K; Hansson O
    Neurology; 2018 Aug; 91(9):e867-e877. PubMed ID: 30054439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes.
    Cicognola C; Mattsson-Carlgren N; van Westen D; Zetterberg H; Blennow K; Palmqvist S; Ahmadi K; Strandberg O; Stomrud E; Janelidze S; Hansson O
    Neurology; 2023 Jul; 101(1):e30-e39. PubMed ID: 37137722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study.
    Lane CA; Barnes J; Nicholas JM; Sudre CH; Cash DM; Parker TD; Malone IB; Lu K; James SN; Keshavan A; Murray-Smith H; Wong A; Buchanan SM; Keuss SE; Gordon E; Coath W; Barnes A; Dickson J; Modat M; Thomas D; Crutch SJ; Hardy R; Richards M; Fox NC; Schott JM
    Lancet Neurol; 2019 Oct; 18(10):942-952. PubMed ID: 31444142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study.
    Debette S; Beiser A; DeCarli C; Au R; Himali JJ; Kelly-Hayes M; Romero JR; Kase CS; Wolf PA; Seshadri S
    Stroke; 2010 Apr; 41(4):600-6. PubMed ID: 20167919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.
    Craig-Schapiro R; Perrin RJ; Roe CM; Xiong C; Carter D; Cairns NJ; Mintun MA; Peskind ER; Li G; Galasko DR; Clark CM; Quinn JF; D'Angelo G; Malone JP; Townsend RR; Morris JC; Fagan AM; Holtzman DM
    Biol Psychiatry; 2010 Nov; 68(10):903-12. PubMed ID: 21035623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Ng KP; Therriault J; Kang MS; Pascoal TA; Rosa-Neto P; Gauthier S;
    Transl Neurodegener; 2018; 7():23. PubMed ID: 30311914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort.
    Lane CA; Barnes J; Nicholas JM; Sudre CH; Cash DM; Malone IB; Parker TD; Keshavan A; Buchanan SM; Keuss SE; James SN; Lu K; Murray-Smith H; Wong A; Gordon E; Coath W; Modat M; Thomas D; Richards M; Fox NC; Schott JM
    JAMA Neurol; 2020 Feb; 77(2):175-183. PubMed ID: 31682678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
    Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
    J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
    Jansen WJ; Janssen O; Tijms BM; Vos SJB; Ossenkoppele R; Visser PJ; ; Aarsland D; Alcolea D; Altomare D; von Arnim C; Baiardi S; Baldeiras I; Barthel H; Bateman RJ; Van Berckel B; Binette AP; Blennow K; Boada M; Boecker H; Bottlaender M; den Braber A; Brooks DJ; Van Buchem MA; Camus V; Carill JM; Cerman J; Chen K; Chételat G; Chipi E; Cohen AD; Daniels A; Delarue M; Didic M; Drzezga A; Dubois B; Eckerström M; Ekblad LL; Engelborghs S; Epelbaum S; Fagan AM; Fan Y; Fladby T; Fleisher AS; Van der Flier WM; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Frings L; Frisoni GB; Fröhlich L; Gabryelewicz T; Gertz HJ; Gill KD; Gkatzima O; Gómez-Tortosa E; Grimmer T; Guedj E; Habeck CG; Hampel H; Handels R; Hansson O; Hausner L; Hellwig S; Heneka MT; Herukka SK; Hildebrandt H; Hodges J; Hort J; Huang CC; Iriondo AJ; Itoh Y; Ivanoiu A; Jagust WJ; Jessen F; Johannsen P; Johnson KA; Kandimalla R; Kapaki EN; Kern S; Kilander L; Klimkowicz-Mrowiec A; Klunk WE; Koglin N; Kornhuber J; Kramberger MG; Kuo HC; Van Laere K; Landau SM; Landeau B; Lee DY; de Leon M; Leyton CE; Lin KJ; Lleó A; Löwenmark M; Madsen K; Maier W; Marcusson J; Marquié M; Martinez-Lage P; Maserejian N; Mattsson N; de Mendonça A; Meyer PT; Miller BL; Minatani S; Mintun MA; Mok VCT; Molinuevo JL; Morbelli SD; Morris JC; Mroczko B; Na DL; Newberg A; Nobili F; Nordberg A; Olde Rikkert MGM; de Oliveira CR; Olivieri P; Orellana A; Paraskevas G; Parchi P; Pardini M; Parnetti L; Peters O; Poirier J; Popp J; Prabhakar S; Rabinovici GD; Ramakers IH; Rami L; Reiman EM; Rinne JO; Rodrigue KM; Rodríguez-Rodriguez E; Roe CM; Rosa-Neto P; Rosen HJ; Rot U; Rowe CC; Rüther E; Ruiz A; Sabri O; Sakhardande J; Sánchez-Juan P; Sando SB; Santana I; Sarazin M; Scheltens P; Schröder J; Selnes P; Seo SW; Silva D; Skoog I; Snyder PJ; Soininen H; Sollberger M; Sperling RA; Spiru L; Stern Y; Stomrud E; Takeda A; Teichmann M; Teunissen CE; Thompson LI; Tomassen J; Tsolaki M; Vandenberghe R; Verbeek MM; Verhey FRJ; Villemagne V; Villeneuve S; Vogelgsang J; Waldemar G; Wallin A; Wallin ÅK; Wiltfang J; Wolk DA; Yen TC; Zboch M; Zetterberg H
    JAMA Neurol; 2022 Mar; 79(3):228-243. PubMed ID: 35099509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Mitochondrial DNA Copy Number With Brain MRI Markers and Cognitive Function: A Meta-analysis of Community-Based Cohorts.
    Zhang Y; Liu X; Wiggins KL; Kurniansyah N; Guo X; Rodrigue AL; Zhao W; Yanek LR; Ratliff SM; Pitsillides A; Aguirre Patiño JS; Sofer T; Arking DE; Austin TR; Beiser AS; Blangero J; Boerwinkle E; Bressler J; Curran JE; Hou L; Hughes TM; Kardia SLR; Launer LJ; Levy D; Mosley TH; Nasrallah IM; Rich SS; Rotter JI; Seshadri S; Tarraf W; González KA; Ramachandran V; Yaffe K; Nyquist PA; Psaty BM; DeCarli CS; Smith JA; Glahn DC; González HM; Bis JC; Fornage M; Heckbert SR; Fitzpatrick AL; Liu C; Satizabal CL;
    Neurology; 2023 May; 100(18):e1930-e1943. PubMed ID: 36927883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.
    Brosseron F; Maass A; Kleineidam L; Ravichandran KA; Kolbe CC; Wolfsgruber S; Santarelli F; Häsler LM; McManus R; Ising C; Röske S; Peters O; Cosma NC; Schneider LS; Wang X; Priller J; Spruth EJ; Altenstein S; Schneider A; Fliessbach K; Wiltfang J; Schott BH; Buerger K; Janowitz D; Dichgans M; Perneczky R; Rauchmann BS; Teipel S; Kilimann I; Görß D; Laske C; Munk MH; Düzel E; Yakupow R; Dobisch L; Metzger CD; Glanz W; Ewers M; Dechent P; Haynes JD; Scheffler K; Roy N; Rostamzadeh A; Spottke A; Ramirez A; Mengel D; Synofzik M; Jucker M; Latz E; Jessen F; Wagner M; Heneka MT;
    Alzheimers Res Ther; 2023 Jan; 15(1):13. PubMed ID: 36631909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth Differentiation Factor 15 and NT-proBNP as Blood-Based Markers of Vascular Brain Injury and Dementia.
    McGrath ER; Himali JJ; Levy D; Conner SC; DeCarli C; Pase MP; Ninomiya T; Ohara T; Courchesne P; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    J Am Heart Assoc; 2020 Oct; 9(19):e014659. PubMed ID: 32921207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study.
    Hughes TM; Wagenknecht LE; Craft S; Mintz A; Heiss G; Palta P; Wong D; Zhou Y; Knopman D; Mosley TH; Gottesman RF
    Neurology; 2018 Apr; 90(14):e1248-e1256. PubMed ID: 29549223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
    Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
    JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.